Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma-Reference-Cited by-同舟云学术

Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma

Published:2021-03-31 Issue:3 Volume:39 Page:293-303
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Genuardi Elisa¹^ORCID,Klous Petra²,Mantoan Barbara¹,Drandi Daniela¹,Ferrante Martina¹,Cavallo Federica¹³,Alessandria Beatrice¹,Dogliotti Irene¹³,Grimaldi Daniele¹³,Ragaini Simone¹³,Clerico Michele¹³,Lo Schirico Mariella¹,Saraci Elona⁴,Yilmaz Mehmet²,Zaccaria Gian Maria¹,Cortelazzo Sergio⁵,Vitolo Umberto⁶,Luminari Stefano⁷⁸,Federico Massimo⁸,Boccadoro Mario¹³,Min Max²,Splinter Erik²,Ladetto Marco⁹,Ferrero Simone¹³

Affiliation:

1. Department of Molecular Biotechnology and Health Sciences Division of Hematology University of Torino Torino Italy

2. Cergentis B.V. Utrecht The Netherlands

3. Division of Hematology 1 AOU “Città della Salute e della Scienza di Torino” Torino Italy

4. European Myeloma Network Onlus Torino Italy

5. Oncology Unit Humanitas/Gavazzeni Clinic Bergamo Italy

6. Department of Oncology Division of Hematology AOU Città della Salute e della Scienza di Torino Torino Italy

7. Hematology Unit Azienda USL IRCCS di Reggio Emilia, Reggio Emilia Modena Italy

8. Medical Oncology, CHIMOMO department University of Modena and Reggio Emilia Modena Italy

9. Division of Hematology Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo Alessandria Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2864

Reference27 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

2. How to manage mantle cell lymphoma

3. Follicular lymphoma: 2014 update on diagnosis and management

4. CD5-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis

5. Minimal Residual Disease Detection in Mantle Cell Lymphoma: Technical Aspects and Clinical Relevance

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial;The Lancet Haematology;2024-07

2. AID in non-Hodgkin B-cell lymphomas: The consequences of on- and off-target activity;Advances in Immunology;2024

3. Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell Lymphoma;Current Treatment Options in Oncology;2023-05-30

4. Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma;Blood;2022-09-22

5. Mapping transgene insertion sites reveals the α-Cre transgene expression in both developing retina and olfactory neurons;Communications Biology;2022-05-03